• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除术后新发逼尿肌活动低下和其他尿动力学发现:系统评价。

De Novo Detrusor Underactivity and Other Urodynamic Findings after Radical Prostatectomy: A Systematic Review.

机构信息

Urology Clinic, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

出版信息

Medicina (Kaunas). 2022 Mar 4;58(3):381. doi: 10.3390/medicina58030381.

DOI:10.3390/medicina58030381
PMID:35334557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949898/
Abstract

The aim of this systematic review is to evaluate the impact of radical prostatectomy (RP) on bladder function, with special attention towards detrusor underactivity investigated with the means of urodynamic evaluation. The review was performed in accordance with the PRISMA statement and was registered in the PROSPERO (ID#: CRD42020223480). The studied population was limited to men with prostate cancer who underwent urodynamic study prior to and after radical prostatectomy. Eight hundred twenty-seven studies were screened, with twenty-five finally included. A qualitative analysis was performed. Rates of detrusor underactivity (DU) before surgery were reported in eight studies and ranged from 1.6% to 75% (median of 40.8%). DU occurred de novo after RP in 9.1% to 37% of patients (median of 29.1%). On the other hand, preexisting DU resolved in 7% to 35.5% of affected men. Detrusor overactivity (DO) was the most frequently reported outcome, being assessed in 23 studies. The rate of DO preoperatively was from 5% to 76% (median of 25%). De novo was reported in 2.3-54.4% of patients (median of 15%) and resolved after RP in 19.6% to 87.5% (median of 33%) of affected patients. Baseline rates of bladder outlet obstruction (BOO) varied between studies from 19% to 59.3%, with a median of 27.8%. The most pronounced change after surgery was the resolution of BOO in 88% to 93.8% (median of 92%) of affected patients. Rates of de novo impaired bladder compliance (IBC) varied from 3.2% to 41.3% (median of 13.3%), whereas the resolution of IBC was reported with rates ranging from 0% to 47% (median of 4.8%). BOO, DO, and DU are frequently diagnosed in men scheduled for RP. BOO is improved after RP in most patients; however, there is still a substantial rate of patients with de novo DU as well as DO which may impair functional outcomes and quality of life.

摘要

本系统评价的目的是评估根治性前列腺切除术 (RP) 对膀胱功能的影响,特别关注尿动力学评估中发现的逼尿肌活动低下。该评价是按照 PRISMA 声明进行的,并在 PROSPERO(ID#: CRD42020223480)中进行了注册。研究人群仅限于接受根治性前列腺切除术之前和之后进行尿动力学研究的前列腺癌男性。共筛选了 827 项研究,最终纳入了 25 项研究。进行了定性分析。8 项研究报告了术前逼尿肌活动低下 (DU) 的发生率,范围为 1.6%至 75%(中位数为 40.8%)。9.1%至 37%的患者(中位数为 29.1%)在 RP 后新发 DU。另一方面,7%至 35.5%的受影响男性的术前 DU 得到缓解。逼尿肌过度活动 (DO) 是最常报告的结果,有 23 项研究对此进行了评估。术前 DO 的发生率为 5%至 76%(中位数为 25%)。2.3%至 54.4%的患者(中位数为 15%)出现新发 DO,受影响患者中有 19%至 87.5%(中位数为 33%)在 RP 后得到缓解。膀胱出口梗阻 (BOO) 的基线发生率在研究之间从 19%到 59.3%不等,中位数为 27.8%。手术后最明显的变化是 88%至 93.8%(中位数为 92%)的受影响患者的 BOO 得到缓解。新发膀胱顺应性受损 (IBC) 的发生率从 3.2%到 41.3%(中位数为 13.3%)不等,而 IBC 的缓解率从 0%到 47%(中位数为 4.8%)不等。接受 RP 的男性常被诊断为 BOO、DO 和 DU。大多数接受 RP 的患者 BOO 得到改善,但仍有相当一部分患者新发 DU 和 DO,这可能会影响功能结局和生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b5/8949898/177489eaa004/medicina-58-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b5/8949898/177489eaa004/medicina-58-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b5/8949898/177489eaa004/medicina-58-00381-g001.jpg

相似文献

1
De Novo Detrusor Underactivity and Other Urodynamic Findings after Radical Prostatectomy: A Systematic Review.根治性前列腺切除术后新发逼尿肌活动低下和其他尿动力学发现:系统评价。
Medicina (Kaunas). 2022 Mar 4;58(3):381. doi: 10.3390/medicina58030381.
2
Systematic review and evaluation of methods of assessing urinary incontinence.尿失禁评估方法的系统评价与评估
Health Technol Assess. 2006 Feb;10(6):1-132, iii-iv. doi: 10.3310/hta10060.
3
Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel.女性膀胱出口梗阻的诊断测试:来自欧洲泌尿外科学会非神经源性女性下尿路症状指南小组的系统评价
Eur Urol Focus. 2022 Jul;8(4):1015-1030. doi: 10.1016/j.euf.2021.09.003. Epub 2021 Sep 17.
4
Benefits and Harms of Conservative, Pharmacological, and Surgical Management Options for Women with Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel.女性膀胱出口梗阻保守、药物和手术治疗选择的获益与危害:欧洲泌尿外科学会非神经源性女性下尿路症状指南小组的系统评价。
Eur Urol Focus. 2022 Sep;8(5):1340-1361. doi: 10.1016/j.euf.2021.10.006. Epub 2021 Oct 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Cryotherapy for localised prostate cancer.局部前列腺癌的冷冻疗法。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005010. doi: 10.1002/14651858.CD005010.pub2.
8
Long-term intravesical oxybutynin for neurogenic bladder in children has good urodynamic and renal outcome.长期膀胱内注射奥昔布宁治疗儿童神经源性膀胱具有良好的尿动力学和肾脏预后。
J Pediatr Urol. 2025 Jun;21(3):661-669. doi: 10.1016/j.jpurol.2025.01.015. Epub 2025 Jan 28.
9
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
10
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.

引用本文的文献

1
Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives.膀胱过度活动症和逼尿肌活动低下:新进展与展望。
Int J Mol Sci. 2023 Oct 24;24(21):15517. doi: 10.3390/ijms242115517.
2
Baseline factors and surgical procedures affecting changes in lower urinary tract symptoms after robot-assisted radical prostatectomy: the impact of nerve-sparing.影响机器人辅助根治性前列腺切除术后下尿路症状变化的基线因素和手术操作:保留神经的影响
Int Urol Nephrol. 2024 Mar;56(3):989-997. doi: 10.1007/s11255-023-03859-9. Epub 2023 Oct 31.
3
Transcriptomics Reveals Molecular Features of the Bilateral Pelvic Nerve Injury Rat Model of Detrusor Underactivity.

本文引用的文献

1
Urodynamic evaluation before and after to RARP to identify pre and intraoperative factors affecting postoperative continence.行根治性前列腺切除术(RARP)前后的尿动力学评估,以确定影响术后控尿的术前和术中因素。
Neurourol Urodyn. 2021 Jun;40(5):1147-1153. doi: 10.1002/nau.24650. Epub 2021 Apr 13.
2
Prevalence and predictors of postoperative detrusor underactivity after robot-assisted radical prostatectomy: A prospective observational study.机器人辅助根治性前列腺切除术后逼尿肌活动不足的发生率及预测因素:一项前瞻性观察研究。
Int J Urol. 2021 Jul;28(7):734-740. doi: 10.1111/iju.14549. Epub 2021 Mar 20.
3
Urodynamic evaluation of patients with localized prostate cancer before and 4 months after robotic radical prostatectomy.
转录组学揭示了逼尿肌活动不足的双侧盆神经损伤大鼠模型的分子特征。
Biomolecules. 2023 Aug 18;13(8):1260. doi: 10.3390/biom13081260.
机器人辅助根治性前列腺切除术前和术后 4 个月局部前列腺癌患者的尿动力学评估。
Sci Rep. 2021 Feb 11;11(1):3632. doi: 10.1038/s41598-021-83143-x.
4
Lower Urinary Tract Functional Assessment of Men Undergoing Radical Prostatectomy: Correlation of Preoperative Clinical and Urodynamic Parameters.接受根治性前列腺切除术男性的下尿路功能评估:术前临床参数与尿动力学参数的相关性
Int Neurourol J. 2021 Jun;25(2):157-163. doi: 10.5213/inj.2040238.119. Epub 2021 Jan 19.
5
Impact of radical prostatectomy on bladder function as demonstrated on urodynamics study-A systematic review.根治性前列腺切除术对尿动力学研究中膀胱功能的影响——系统评价。
Neurourol Urodyn. 2021 Feb;40(2):582-603. doi: 10.1002/nau.24606. Epub 2021 Jan 21.
6
Baseline patient reported outcomes data shows high prevalence of overactive bladder, sexual dysfunction, depression and anxiety in Canadian men with newly diagnosed localized prostate cancer.患者报告的基线结局数据显示,在加拿大新诊断为局限性前列腺癌的男性中,膀胱过度活动症、性功能障碍、抑郁和焦虑的患病率很高。
Transl Androl Urol. 2020 Oct;9(5):2046-2053. doi: 10.21037/tau-20-689.
7
Daily urine loss immediately after urethral catheter removal may be an effective predictor of long-term urinary incontinence following robot-assisted laparoscopic radical prostatectomy.尿道导管移除后立即出现的每日尿失禁可能是机器人辅助腹腔镜根治性前列腺切除术后长期尿失禁的有效预测指标。
Int J Clin Pract. 2021 Apr;75(4):e13736. doi: 10.1111/ijcp.13736. Epub 2020 Dec 11.
8
Transvesical robot-assisted radical prostatectomy: initial experience and surgical outcomes.经膀胱机器人辅助根治性前列腺切除术:初步经验和手术结果。
BJU Int. 2020 Aug;126(2):300-308. doi: 10.1111/bju.15111. Epub 2020 Jun 1.
9
Role of miRNAs in prostate cancer: Do we really know everything?miRNAs 在前列腺癌中的作用:我们真的了解一切吗?
Urol Oncol. 2020 Jul;38(7):623-635. doi: 10.1016/j.urolonc.2020.03.007. Epub 2020 Apr 10.
10
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment.逼尿肌过度活动和活动不足:对与良性前列腺增生症诊断和治疗相关的下尿路症状的影响。
Minerva Urol Nephrol. 2021 Feb;73(1):59-71. doi: 10.23736/S2724-6051.20.03678-4. Epub 2020 Jan 30.